Dr. Robert Methvin is a Frisco, Texas based chiropractor who is specialized as General Chiropractic. Active license number of Dr. Robert Methvin as General Chiropractic is 9857 in Texas. Dr. Robert Methvin is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Robert Methvin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
General Chiropractic
Credentials:
DC
Gender:
Male
Practice Address:
5850 Town & Country Blvd, Suite 101, Frisco, Texas, 75034
Phone:
469-633-1273
Fax:
972-712-6026
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790895522
NPI Enumeration Date:
30 Aug, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Robert Methvin are as mentioned below.
License Number
Specialization
State
Status
9857
Chiropractor
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1853 Juniper Ln, Lewisville, Texas
Zip:
75077
Phone Number:
972-353-4650
Fax Number:
972-712-6026
Patients can reach Dr. Robert Methvin at 5850 Town & Country Blvd, Suite 101, Frisco, Texas or can call to book an appointment on 469-633-1273. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.